• Molecular NameNitrazepam
  • Synonym1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; 2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-on; 7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one; 7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one; N-desmethylnimetazepam; Nitrazepamum [inn-latin]; NTZ
  • Weight281.271
  • Drugbank_IDDB01595
  • ACS_NO146-22-5
  • Show 3D model
  • LogP (experiment)2.19
  • LogP (predicted, AB/LogP v2.0)2.03
  • pka3.2, 10.8
  • LogD (pH=7, predicted)2.03
  • Solubility (experiment)0.045 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.55
  • LogSw (predicted, AB/LogsW2.0)0.05
  • Sw (mg/ml) (predicted, ACD/Labs)0.08
  • No.of HBond Donors1
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds2
  • TPSA90.29
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA hypnotic drug with sedative and motor impairing properties, anxiolytic, amnestic, anticonvulsant and skeletal muscle relaxant properties.
  • Absorption_value95.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability78.0
  • Protein binding86.5
  • Volume of distribution (VD)2 to 3 L/kg, increased in elderly subjects
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life28 h
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A